These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

757 related items for PubMed ID: 30642734

  • 1. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study.
    Ristow O, Rückschloß T, Müller M, Berger M, Kargus S, Pautke C, Engel M, Hoffmann J, Freudlsperger C.
    J Craniomaxillofac Surg; 2019 Mar; 47(3):491-499. PubMed ID: 30642734
    [Abstract] [Full Text] [Related]

  • 2. Medication-related osteonecrosis of the jaw in oncological patients with skeletal metastases: conservative treatment is effective up to stage 2.
    Coropciuc RG, Grisar K, Aerden T, Schol M, Schoenaers J, Politis C.
    Br J Oral Maxillofac Surg; 2017 Oct; 55(8):787-792. PubMed ID: 28760314
    [Abstract] [Full Text] [Related]

  • 3. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A, Goto TK, Ojiri H, Takagiwa M, Hiraga C, Okamura M, Hasegawa S, Okuyama Y, Ogino N, Yamauchi H, Kobashi Y, Yamazoe S, Munetomo Y, Mogami T, Nomura T.
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [Abstract] [Full Text] [Related]

  • 4. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B, Muschitz Ch, Gruber R, Brandtner Ch, Svejda Ch, Gasser RW, Santler G, Dimai HP.
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [Abstract] [Full Text] [Related]

  • 5. Conservative non-surgical management in medication related osteonecrosis of the jaw: A retrospective study.
    Albanese M, Zotti F, Capocasale G, Bonetti S, Lonardi F, Nocini PF.
    Clin Exp Dent Res; 2020 Oct; 6(5):512-518. PubMed ID: 32614524
    [Abstract] [Full Text] [Related]

  • 6. Osteonecrosis of the jaw in patients treated with denosumab: A multicenter case series.
    Aljohani S, Gaudin R, Weiser J, Tröltzsch M, Ehrenfeld M, Kaeppler G, Smeets R, Otto S.
    J Craniomaxillofac Surg; 2018 Sep; 46(9):1515-1525. PubMed ID: 29983309
    [Abstract] [Full Text] [Related]

  • 7. Denosumab-related osteonecrosis of the jaw following non-surgical periodontal therapy: A case report.
    Diniz-Freitas M, Fernández-Feijoo J, Diz Dios P, Pousa X, Limeres J.
    J Clin Periodontol; 2018 May; 45(5):570-577. PubMed ID: 29479739
    [Abstract] [Full Text] [Related]

  • 8. Management of Medication-Related Osteonecrosis of the Jaw.
    Williams WB, O'Ryan F.
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):517-25. PubMed ID: 26515735
    [Abstract] [Full Text] [Related]

  • 9. Medication-related osteonecrosis of the jaw: Surgical or non-surgical treatment?
    Favia G, Tempesta A, Limongelli L, Crincoli V, Maiorano E.
    Oral Dis; 2018 Mar; 24(1-2):238-242. PubMed ID: 29480596
    [Abstract] [Full Text] [Related]

  • 10. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
    Hauer L, Jambura J, Hrusak D, Chalupova M, Posta P, Rusnak S, Vyskocil V.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws.
    Klingelhöffer C, Zeman F, Meier J, Reichert TE, Ettl T.
    J Craniomaxillofac Surg; 2016 Oct; 44(10):1694-1699. PubMed ID: 27591091
    [Abstract] [Full Text] [Related]

  • 12. Issues with the surgical treatment of antiresorptive agent-related osteonecrosis of the jaws.
    Kagami H, Inoue M, Kobayashi A, Taguchi A, Li X, Yoshizawa M.
    Oral Dis; 2018 Mar; 24(1-2):52-56. PubMed ID: 29480637
    [Abstract] [Full Text] [Related]

  • 13. Periosteal reaction of medication-related osteonecrosis of the jaw (MRONJ): clinical significance and changes during conservative therapy.
    Soutome S, Otsuru M, Hayashida S, Yanamoto S, Sasaki M, Takagi Y, Sumi M, Kojima Y, Sawada S, Iwai H, Umeda M, Saito T.
    Support Care Cancer; 2021 Nov; 29(11):6361-6368. PubMed ID: 33884506
    [Abstract] [Full Text] [Related]

  • 14. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
    Matsumoto A, Sasaki M, Schmelzeisen R, Oyama Y, Mori Y, Voss PJ.
    Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
    [Abstract] [Full Text] [Related]

  • 15. Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up.
    Nisi M, Karapetsa D, Gennai S, Ramaglia L, Graziani F, Gabriele M.
    J Craniomaxillofac Surg; 2018 Jul; 46(7):1153-1158. PubMed ID: 29802059
    [Abstract] [Full Text] [Related]

  • 16. Osteonecrosis of the jaw in patients transitioning from bisphosphonates to denosumab treatment for osteoporosis.
    Voss PJ, Steybe D, Poxleitner P, Schmelzeisen R, Munzenmayer C, Fuellgraf H, Stricker A, Semper-Hogg W.
    Odontology; 2018 Oct; 106(4):469-480. PubMed ID: 29713913
    [Abstract] [Full Text] [Related]

  • 17. Surgical and conservative treatment outcomes of medication-related osteonecrosis of the jaw located at tori: a retrospective study.
    Amin H, Andersen SWM, Jensen SS, Kofod T.
    Oral Maxillofac Surg; 2024 Sep; 28(3):1117-1125. PubMed ID: 38418702
    [Abstract] [Full Text] [Related]

  • 18. Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: A prospective cohort study.
    Otto S, Ristow O, Pache C, Troeltzsch M, Fliefel R, Ehrenfeld M, Pautke C.
    J Craniomaxillofac Surg; 2016 Aug; 44(8):1073-80. PubMed ID: 27263757
    [Abstract] [Full Text] [Related]

  • 19. [Bisphosphonate and denosumab-related osteonecrosis of the jaw: Epidemiology, diagnosis and management].
    Dupic G, Collangettes D, Dillies AF, Calvet L, Tournilhac O, Bay JO, Mahammedi H.
    Bull Cancer; 2015 Dec; 102(12):1010-9. PubMed ID: 26607453
    [Abstract] [Full Text] [Related]

  • 20. Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.
    Bagan J, Peydró A, Calvo J, Leopoldo M, Jiménez Y, Bagan L.
    Oral Dis; 2016 May; 22(4):324-9. PubMed ID: 26818808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.